PALM BAY, Fla., Oct. 9, 2024 /PRNewswire/ — Reticulate Micro, Inc. (“Reticulate Micro” or the “Company”), a commercial and defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment, today announced that it has submitted the necessary application materials with OTC Markets Group, Inc. (“OTC Markets”) to quote its securities on the OTCQB® Venture Market (“OTCQB”). This move marks a significant milestone in the Company’s growth strategy, providing enhanced visibility and upon approval of the company’s application, liquidity for investors while continuing its focus on driving innovation and business expansion.

OTCQB is designed for early-stage and developing U.S. and international companies. It offers investors transparent trading, real-time quotes, and better information availability, making it an attractive option for companies seeking to broaden their shareholder base. Reticulate Micro believes that joining OTCQB will increase access to capital markets, enhance shareholder value, and position the Company for long-term success.

“We are excited to take this next step in our journey by applying for quotation on OTCQB,” said Joshua Cryer, CEO of Reticulate Micro. “This strategic move will allow us to reach a broader audience of investors and provide them with an opportunity to participate in the growth of Reticulate Micro as we continue to execute on our business model. We believe the OTCQB quotation will be a key element in our capital markets strategy, enabling greater liquidity and transparency for our shareholders. Most importantly, all those that invested in our Regulation A offering received shares that were qualified under our Regulation A offering statement such that those shares may be freely traded on OTCQB once we are cleared for quotation by OTC Markets and FINRA.”

The Company will continue to update investors as the process moves forward. 

About Reticulate Micro, Inc.

Reticulate Micro, Inc., with headquarters in Palm Bay, Florida, is a commercial and defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment. Reticulate is building one of the world’s first post-quantum-encrypted open-systems platforms for robust video streaming, simplified terminal management and satellite mobile connectivity in austere environments and diverse orbital regimes. Serving the defense, mobility, broadcasting, enterprise infrastructure monitoring and security sectors, Reticulate Micro and its newest business segment Reticulate Space embrace open standards across its software and product offerings.

Cautionary Note Regarding Forward-Looking Statements:

This press release contains forward-looking statements that are subject to various risks and uncertainties. In addition, our representatives or we may make forward-looking statements orally or in writing from time to time. We base these forward-looking statements on our expectations and projections about future events, which we derive from the available information. Such forward-looking statements relate to future events or our future performance, including our financial performance and projections, revenue and earnings growth, and business prospects and opportunities. You can identify forward-looking statements by those that are not historical facts, particularly those that use terminology such as “intends,” “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. Although the Company believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Forward-looking statements speak only as of the date of the document in which they are contained, and the Company does not undertake any duty to update any forward-looking statements except as may be required by law.

Important Notice the Regarding Our Regulation A Offering

An offering statement regarding our offering of units consisting of one share of class A common stock and a warrant to purchase one share of class A common stock has been filed with the SEC. The SEC has qualified that offering statement, which means that Reticulate Micro may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement through this link.

Investing in a public offering like our Regulation A offering is subject to unique risks, tolerance for volatility, and potential loss of your investment, that investors should be aware of prior to making an investment decision. Please carefully review the risk factors contained in the offering circular for this offering. For more information about Regulation A offerings, including the unique risks associated with these types of offerings, please click on the SEC’s Investor Alert.

Neither this document nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any security by Reticulate Micro or any third party. The content of this document is provided for general information purposes only and is not intended to solicit the purchase of securities or to be used as investment, legal or tax advice. A securities offering by Reticulate Micro is only being made pursuant to the offering circular described above. The content of this document is qualified in its entirety by such offering circular. Prospective investors are urged to consult with their own, investment, legal and tax advisors prior to making any investment in Reticulate Micro.

Contact:
Media:
Reticulate Micro Media Relations
media@reticulate.io

Investor Relations:
Reticulate Micro Investor Relations
ir@reticulate.io

View original content to download multimedia:https://www.prnewswire.com/news-releases/reticulate-micro-announces-application-submission-to-quote-on-otcqb-venture-market-providing-direct-path-to-liquidity-for-regulation-a-investors-302272027.html

SOURCE Reticulate Micro, Inc.

The medical software company closes the care gap in reproductive health by providing clinical decision support and virtual care pathways. 

/PRNewswire/ —

LEVY Health, an innovator in the field of reproductive health technology, has raised $4.5 million led by San Francisco-based venture firm XYZ Venture Capital, with additional participation from Atlantic Labs and Possible Ventures.

The new funding will be used to integrate LEVY Health’s virtual care pathways, which reduce time to treatment from years to weeks, with electronic medical record software. It will also fuel the company’s growth across women’s health and reproductive care, with solutions for fertility clinics, fertility benefit providers, laboratories, and biopharma companies.

Tackling the Reproductive Care Gap

Studies show that 80-85% of women are diagnosed with an endocrine disorder at least once in their lifetime, and 20% of individuals in the U.S. struggle with fertility problems. However, the shortage of women’s healthcare providers and reproductive endocrinologists (REIs) leaves millions of patients facing long, excruciating wait times for diagnoses and treatment. LEVY Health bridges this gap by applying smart algorithms, enabling precision diagnostics and personalized recommendations for treatment.

Founded by three women in 2021, LEVY Health has developed clinical decision support based on medical guidelines, clinical studies, and lab data. The company’s software combines health information with lab results, defining virtual care pathways for patients. Patients and providers benefit from dynamic medical history intake, automated lab orders and interpretation of results, patient triaging to lower and higher complexity treatments, patient education, and direct virtual care. LEVY Health’s software supports 152 diagnoses and provides treatment recommendations in line with ASRM, ESHRE, and ACOG standards, ensuring accurate diagnoses in weeks instead of years.

“Our platform can be seen as a clinic’s highly educated, virtual care coordinator, completing patient’s fertility work-up and educating them about next steps,” says Caroline Mitterdorfer, Co-founder and CEO of LEVY Health. “Physicians can choose at which point they’ll take over, and for those customers who don’t provide care themselves, we have an offering that helps them partner with providers across most US states. Either way, we enable providers to focus on treatment planning at the first consultation.”

Healthcare providers using the software see a reduction in treatment timelines from an average of 145 days to just 45, with significantly less physician time required per patient. By automating many administrative tasks, LEVY Health’s platform enables providers to dedicate more of their time to patient care and treatment.

The company’s clients include industry leaders such as fertility, family building, and women’s health benefits provider, Progyny, US fertility clinic groups Boston IVF and Texas Fertility Center, the Mexican fertility group Fertilidad Integral, as well as the US-based egg donation agency, Everie.

Plans for the Future

The global fertility market was valued at $34.7 billion in 2023 and is projected to grow to $62.8 billion by 2033. Due to the shortage of providers in the United States, clinics are increasingly turning to software solutions to improve efficiency and triaging, creating significant opportunities for companies like LEVY Health. “We started LEVY Health with a clear vision: to close the reproductive care gap and ensure that more women are accurately diagnosed in a timely manner, thereby lowering treatment costs and increasing their chances for a healthy pregnancy”, says Mitterdorfer. “This funding will allow us to access more verticals in women’s health and to build tailored solutions for women in different reproductive phases of their lives.” The company is currently working on applications for fertility clinics, fertility benefit providers, laboratories, and biopharma companies.

“LEVY Health is demonstrating to the entire healthcare market what is possible when you build solutions that help providers expedite the parts of their job that keep them from providing the standard of care they wish they could”, says Ross Fubini, Founder & Managing Partner of XYZ Venture Capital. “This makes life better for everyone – providers can serve their patients better while unlocking new revenue models, and patients themselves no longer have to sit with uncertainty during crucial moments. I have conviction this is just the beginning of the change LEVY Health is going to make.” 

About XYZ Venture Capital
XYZ Venture Capital is a pre-seed and seed stage venture capital firm based in San Francisco. Founded in 2017, it’s known for its investments in Anduril and other emerging leaders in public sector and defence technology, as well as in breakout startups Verkada, Newfront Insurance, Apex Space, and Chapter. The XYZ team looks to invest in founders with lived experience and key insights into tech-forgotten industries, and specialises in helping them optimise their future rounds of funding. More at xyz.vc.

For more information, please visit www.levy.health or contact:

Lena Jäkel
Head of Marketing
E-mail: lena@levy.health
Phone: (415) 969-3373

View original content to download multimedia:https://www.prnewswire.com/news-releases/levy-health-secures-4-5-million-in-funding-to-expedite-diagnosis-and-care-in-reproductive-health-302272032.html

SOURCE Levy Health USA, Inc.

Agora will leverage Wormhole NTT (native token transfers) to unite AUSD stablecoin liquidity across all blockchains

NEW YORK, Oct. 9, 2024 /PRNewswire/ — Agora, the Dragonfly-backed startup aimed at building an open, inclusive stablecoin network, today announced the selection of Wormhole as a core interoperability provider for their AUSD stablecoin. Currently live on Ethereum, Avalanche, and Sui with over $65M in total value locked (TVL), AUSD is a centralized, credibly neutral stablecoin expanding to all major blockchains. By leveraging Wormhole’s multichain capabilities and secure infrastructure that caters to the development of institutional-grade stablecoins, the integration will unify liquidity across chains and increase AUSD access and transferability. 

Through this collaboration, Agora furthers its mission of developing an open, more inclusive model for participants in stablecoin networks. Agora manages AUSD, a digital dollar minted 1:1 with USD fiat. AUSD is designed to be a secure digital currency, utilizing one of the world’s largest custodian banks to safeguard assets. With Wormhole’s NTT framework Agora can cut liquidity fragmentation by preserving the intrinsic properties of tokens on different chains. Leveraging NTT not only unites the Agora ecosystem but also enhances transparency while reducing transaction fees and other costs. Additionally, NTT enables AUSD to easily expand to additional blockchains, with Solana coming in the near future.

As the provider of one of the fastest-growing stablecoins, “Agora’s selection of Wormhole as an interoperability solution is driven by the knowledge that early multichain support will improve user experience and support our rapid expansion to other ecosystems. This integration reduces barriers standing in the way of accessing, transferring, and using AUSD,” said Nick van Eck, CEO and co-founder.

Agora is the latest project to choose Wormhole as a core interoperability solution following the announcement of Wormhole’s latest Era3 Upgrade, which introduced major user experience, speed, and cost reduction improvements to the platform. Most recently, Securitize announced a core partnership with Wormhole to add multichain functionality to their tokenized treasury bills, including BlackRock’s currently $500 million BUIDL fund.

Robinson Burkey, co-founder and CCO of Wormhole Foundation, added: “Agora’s mission to expand access to the US dollar is one that Wormhole Foundation is proud to support. Through Wormhole NTT, Agora customers will benefit from access to more users and liquidity across all major blockchain networks. This partnership reflects our ongoing efforts to increase institutional adoption of digital assets and improve user trust in transacting onchain.”

About Agora 
Agora manages AUSD, a digital dollar minted 1:1 with USD fiat. AUSD is designed to be a secure digital currency, utilizing one of the world’s largest custodian banks to safeguard assets. AUSD enables users to participate in trading, lending and payments. It is the most cost-efficient stablecoin to transact with due to its gas-optimized smart contract, making it ideal for traders and payments. Additionally, Agora offers a forward-thinking payment and operations platform.

About Wormhole
Wormhole is the leading interoperability platform that powers multichain applications and bridges at scale. Wormhole provides developers access to liquidity and users on over 30 leading blockchain networks, enabling use cases that span DeFi, NFTs, governance, and more.

The wider Wormhole network is trusted and used by teams like Circle and Uniswap. To date, the platform has facilitated the transfer of over 45 billion dollars through over 1 billion cross-chain messages.

About Wormhole Foundation
The Wormhole Foundation is the steward of Wormhole—the world’s first generalized messaging protocol. Our mission is to empower passionate people in researching and developing blockchain interoperability technologies. Through grants, research, and ecosystem programs, we seek to enable teams to build secure, open-source, and decentralized products within the Wormhole ecosystem.

Media Contact
M Group Strategic Communications (On behalf of Wormhole Foundation)
wormhole@mgroupsc.com

View original content:https://www.prnewswire.com/news-releases/agora-selects-wormhole-as-core-interoperability-solution-for-ausd-stablecoin-302272031.html

SOURCE Wormhole Foundation